<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03630198</url>
  </required_header>
  <id_info>
    <org_study_id>181119</org_study_id>
    <nct_id>NCT03630198</nct_id>
  </id_info>
  <brief_title>Pain Outcomes Following Intralesional Corticosteroid Injections</brief_title>
  <official_title>The Use of Local Anesthetic in Intralesional Corticosteroid Injections; A Randomized, Double Blind Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Corticosteroid therapy, including intralesional and topical applications, has many&#xD;
      indications within the fields of Dermatology, Plastic Surgery, and Orthopedics. However,&#xD;
      these injections can be quite painful, which leads many patients to discontinue treatment.&#xD;
&#xD;
      Often, the injection involves a mixture of local anesthetic and corticosteroids despite a&#xD;
      lack of evidence that the use of lidocaine improves pain. Due to the acidic pH, the lidocaine&#xD;
      component of the injection can actually cause a significant burning sensation during the&#xD;
      procedure. Lidocaine does not have anti-inflammatory properties and does not treat the&#xD;
      underlying pathology. By including another medication, lidocaine also adds cost and risk to&#xD;
      the procedure.&#xD;
&#xD;
      The purpose of this study is to see if removing lidocaine from intralesional injections&#xD;
      decreases the pain of injection.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Actual">September 1, 2019</completion_date>
  <primary_completion_date type="Actual">September 1, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Outcome: Visual Analog Scale</measure>
    <time_frame>Assessed 1 minute after the injection (in clinic)</time_frame>
    <description>Assessed using the visual analog scale (0-10 scale). Zero indicates no pain, 10 indicates worst pain ever.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Keloid</condition>
  <condition>Alopecia Areata</condition>
  <condition>Acne</condition>
  <condition>Hypertrophic Scar</condition>
  <condition>Epidermal Inclusion Cyst</condition>
  <condition>Frontal Fibrosing Alopecia</condition>
  <condition>Lichen Plano-Pilaris</condition>
  <condition>Keratoacanthoma</condition>
  <condition>Plaque Psoriasis</condition>
  <condition>Lichen Simplex Chronicus</condition>
  <condition>Prurigo Nodularis</condition>
  <condition>Nummular Eczema</condition>
  <condition>Granuloma Annulare</condition>
  <condition>Morphea</condition>
  <condition>Lichen Planus</condition>
  <arm_group>
    <arm_group_label>Corticosteroid with lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm will include an injection mixture of corticosteroid and lidocaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Corticosteroid with normal saline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will include a mixture of corticosteroid and normal saline. The purpose of normal saline is to keep the volume and concentration similar when compared to the injections containing lidocaine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Corticosteroid with lidocaine</intervention_name>
    <description>Intralesional corticosteroid injection</description>
    <arm_group_label>Corticosteroid with lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Corticosteroid with normal saline</intervention_name>
    <description>Intralesional corticosteroid injection</description>
    <arm_group_label>Corticosteroid with normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  &gt;12 years old presenting with an indication for intralesional steroid injection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unconsentable&#xD;
&#xD;
          -  Not a candidate for corticosteroid injection&#xD;
&#xD;
          -  Contraindication to lidocaine&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian Drolet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>August 9, 2018</study_first_submitted>
  <study_first_submitted_qc>August 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2018</study_first_posted>
  <results_first_submitted>January 10, 2021</results_first_submitted>
  <results_first_submitted_qc>February 18, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 11, 2021</results_first_posted>
  <last_update_submitted>February 18, 2021</last_update_submitted>
  <last_update_submitted_qc>February 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Brian Drolet</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>corticosteroid</keyword>
  <keyword>local anesthetic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epidermal Cyst</mesh_term>
    <mesh_term>Granuloma</mesh_term>
    <mesh_term>Alopecia</mesh_term>
    <mesh_term>Alopecia Areata</mesh_term>
    <mesh_term>Lichen Planus</mesh_term>
    <mesh_term>Prurigo</mesh_term>
    <mesh_term>Granuloma Annulare</mesh_term>
    <mesh_term>Neurodermatitis</mesh_term>
    <mesh_term>Keratoacanthoma</mesh_term>
    <mesh_term>Cicatrix, Hypertrophic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>IPD will not be shared with other researchers</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/98/NCT03630198/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Corticosteroid With Lidocaine</title>
          <description>This arm will include an injection mixture of corticosteroid and lidocaine&#xD;
Corticosteroid with lidocaine: Intralesional corticosteroid injection</description>
        </group>
        <group group_id="P2">
          <title>Corticosteroid With Normal Saline</title>
          <description>This arm will include a mixture of corticosteroid and normal saline. The purpose of normal saline is to keep the volume and concentration similar when compared to the injections containing lidocaine.&#xD;
Corticosteroid with normal saline: Intralesional corticosteroid injection</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Corticosteroid With Lidocaine</title>
          <description>This arm will include an injection mixture of corticosteroid and lidocaine&#xD;
Corticosteroid with lidocaine: Intralesional corticosteroid injection</description>
        </group>
        <group group_id="B2">
          <title>Corticosteroid With Normal Saline</title>
          <description>This arm will include a mixture of corticosteroid and normal saline. The purpose of normal saline is to keep the volume and concentration similar when compared to the injections containing lidocaine.&#xD;
Corticosteroid with normal saline: Intralesional corticosteroid injection</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="13"/>
            <count group_id="B2" value="18"/>
            <count group_id="B3" value="31"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="31"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="31"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33" spread="18.2"/>
                    <measurement group_id="B2" value="52" spread="19.2"/>
                    <measurement group_id="B3" value="43" spread="20.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="31"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                    <count group_id="B2" value="18"/>
                    <count group_id="B3" value="31"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Outcome: Visual Analog Scale</title>
        <description>Assessed using the visual analog scale (0-10 scale). Zero indicates no pain, 10 indicates worst pain ever.</description>
        <time_frame>Assessed 1 minute after the injection (in clinic)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Corticosteroid With Lidocaine</title>
            <description>This arm will include an injection mixture of corticosteroid and lidocaine&#xD;
Corticosteroid with lidocaine: Intralesional corticosteroid injection</description>
          </group>
          <group group_id="O2">
            <title>Corticosteroid With Normal Saline</title>
            <description>This arm will include a mixture of corticosteroid and normal saline. The purpose of normal saline is to keep the volume and concentration similar when compared to the injections containing lidocaine.&#xD;
Corticosteroid with normal saline: Intralesional corticosteroid injection</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Outcome: Visual Analog Scale</title>
          <description>Assessed using the visual analog scale (0-10 scale). Zero indicates no pain, 10 indicates worst pain ever.</description>
          <units>Score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.4" spread="2.4"/>
                    <measurement group_id="O2" value="2.7" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Pain Outcome: Visual Analog Scale</title>
        <description>Assessed using the visual analog scale (0-10 scale). Zero indicates no pain, 10 indicates worst pain ever.</description>
        <time_frame>Assessed at 6 hours and 24 hours after injection</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Corticosteroid With Lidocaine</title>
            <description>This arm will include an injection mixture of corticosteroid and lidocaine&#xD;
Corticosteroid with lidocaine: Intralesional corticosteroid injection</description>
          </group>
          <group group_id="O2">
            <title>Corticosteroid With Normal Saline</title>
            <description>This arm will include a mixture of corticosteroid and normal saline. The purpose of normal saline is to keep the volume and concentration similar when compared to the injections containing lidocaine.&#xD;
Corticosteroid with normal saline: Intralesional corticosteroid injection</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Outcome: Visual Analog Scale</title>
          <description>Assessed using the visual analog scale (0-10 scale). Zero indicates no pain, 10 indicates worst pain ever.</description>
          <units>Score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain (6 hour)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="2.1"/>
                    <measurement group_id="O2" value="0.1" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain (24 hour)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year after injection</time_frame>
      <desc>No difference</desc>
      <group_list>
        <group group_id="E1">
          <title>Corticosteroid With Lidocaine</title>
          <description>This arm will include an injection mixture of corticosteroid and lidocaine&#xD;
Corticosteroid with lidocaine: Intralesional corticosteroid injection</description>
        </group>
        <group group_id="E2">
          <title>Corticosteroid With Normal Saline</title>
          <description>This arm will include a mixture of corticosteroid and normal saline. The purpose of normal saline is to keep the volume and concentration similar when compared to the injections containing lidocaine.&#xD;
Corticosteroid with normal saline: Intralesional corticosteroid injection</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Brian Drolet</name_or_title>
      <organization>Vanderbilt Univeristy Medical center</organization>
      <phone>615-322-2918</phone>
      <email>brian.c.drolet@vumc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

